COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance

Submitted: April 27, 2020
Accepted: June 18, 2020
Published: June 29, 2020
Abstract Views: 4760
PDF: 1736
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Coronavirus Disease (COVID-19) pandemic has so far led to innumerable deaths worldwide. The risk factors so far that have been most studied as poor prognostic factors are old age, individuals with multiple comorbidities and immunocompromised patients. Amongst the chronic lung diseases, most patients with COVID-19 reported so far had asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. Herein, we discuss the significance of restrictive lung disease during the COVID-19 pandemic as a potential risk factor via an example of a patient with kyphoscoliosis who succumbed to death due to COVID-19 pneumonia.



PlumX Metrics


Download data is not yet available.


How to Cite

Sahu, Kamal Kant, Ajay Kumar Mishra, Kevin Martin, and Iryna Chastain. 2020. “COVID-19 and Restrictive Lung Disease: A Deadly Combo to Trip off the Fine Balance”. Monaldi Archives for Chest Disease 90 (2).